Norelgestromin
Alternative Names: MR-130A-01; MR-130A-01 Transdermal patchLatest Information Update: 05 Jun 2024
At a glance
- Originator Viatris
- Class Hormonal contraceptives
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Pregnancy
Most Recent Events
- 09 May 2024 Viatris completes a phase II trial in Pregnancy (Prevention) in Germany (NCT06048536)
- 22 Dec 2023 Phase-II clinical trials in Pregnancy (Prevention) in Germany (Topical) (NCT06048536)